These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8614796)

  • 21. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection.
    Mellors JW; Margolick JB; Phair JP; Rinaldo CR; Detels R; Jacobson LP; Muñoz A
    JAMA; 2007 Jun; 297(21):2349-50. PubMed ID: 17551128
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune clearance of HIV type 1 replication-active cells: a model of two patterns of steady state HIV infection.
    Bucy RP
    AIDS Res Hum Retroviruses; 1999 Feb; 15(3):223-7. PubMed ID: 10052752
    [No Abstract]   [Full Text] [Related]  

  • 24. The moving target: mechanisms of HIV persistence during primary infection.
    Soudeyns H; Pantaleo G
    Immunol Today; 1999 Oct; 20(10):446-50. PubMed ID: 10500291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On high alert.
    Marris E
    Nature; 2010 Jul; 466(7304):S2-3. PubMed ID: 20631700
    [No Abstract]   [Full Text] [Related]  

  • 26. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion.
    de Wolf F; Spijkerman I; Schellekens PT; Langendam M; Kuiken C; Bakker M; Roos M; Coutinho R; Miedema F; Goudsmit J
    AIDS; 1997 Dec; 11(15):1799-806. PubMed ID: 9412697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of antigenic variation on cytotoxic T lymphocyte responses in HIV-1 infection.
    Price DA; Meier UC; Klenerman P; Purbhoo MA; Phillips RE; Sewell AK
    J Mol Med (Berl); 1998 Sep; 76(10):699-708. PubMed ID: 9766848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection.
    Mooij P; Nieuwenhuis IG; Knoop CJ; Doms RW; Bogers WM; Ten Haaft PJ; Niphuis H; Koornstra W; Bieler K; Köstler J; Morein B; Cafaro A; Ensoli B; Wagner R; Heeney JL
    J Virol; 2004 Apr; 78(7):3333-42. PubMed ID: 15016855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A strategy for prophylactic vaccination against HIV.
    Salk J; Bretscher PA; Salk PL; Clerici M; Shearer GM
    Science; 1993 May; 260(5112):1270-2. PubMed ID: 8098553
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.
    Coffin JM
    Science; 1995 Jan; 267(5197):483-9. PubMed ID: 7824947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunopathogenesis and immunotherapy in AIDS virus infections.
    Letvin NL; Walker BD
    Nat Med; 2003 Jul; 9(7):861-6. PubMed ID: 12835706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV results in the frame. Other approaches.
    Bukrinsky M; Manogue K; Cerami A
    Nature; 1995 May; 375(6528):195-6; author reply 198. PubMed ID: 7746316
    [No Abstract]   [Full Text] [Related]  

  • 34. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
    Klein MR; van Baalen CA; Holwerda AM; Kerkhof Garde SR; Bende RJ; Keet IP; Eeftinck-Schattenkerk JK; Osterhaus AD; Schuitemaker H; Miedema F
    J Exp Med; 1995 Apr; 181(4):1365-72. PubMed ID: 7699324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.
    Mellors JW; Rinaldo CR; Gupta P; White RM; Todd JA; Kingsley LA
    Science; 1996 May; 272(5265):1167-70. PubMed ID: 8638160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral pathogenesis: HIV-1 adds fuel to the fire.
    Hofer U
    Nat Rev Microbiol; 2014 Feb; 12(2):74-5. PubMed ID: 24384600
    [No Abstract]   [Full Text] [Related]  

  • 38. [Epidemiology of discordant virologic and immunologic responses in HIV-1 infected patients].
    Thiébaut R; Lewden C; Chêne G
    Med Mal Infect; 2005 Jun; 35 Suppl 2():S31-2. PubMed ID: 15978379
    [No Abstract]   [Full Text] [Related]  

  • 39. AIDS--an autoimmune model.
    Kennedy JR
    Med Hypotheses; 1992 Jan; 37(1):16-9. PubMed ID: 1349151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A; Jin X; Sissons P; Borysiewicz L
    J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.